Efficacy of Inverted Internal Limiting Membrane Flap Technique for Macular Hole Retinal Detachment in Highly Myopic Eyes
| Registry | NCT02896972 |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; non randomized, parallel, masking: single, treatment |
| Enrollment | 32 (Actual) |
| Sponsor | Kyorin University (Other) |
| Conditions | Macular Hole Retinal Detachment |
| Interventions | Vitrectomy (Procedure) |
| Dates | start 2012-04-01, primary completion 2016-03-01, completion 2016-09-01, first posted 2016-09-12, last updated 2017-01-10 |
Related Papers Related Patents Related Grants Related Experts
All trials for Macular Hole Retinal Detachment All trials of Vitrectomy
To evaluate efficacy of vitrectomy with inverted internal limiting membrane (ILM) flap technique for macular hole retinal detachment (MHRD) in highly myopic eyes, and to demonstrate postoperative clinical course of MHRD after inverted ILM flap technique using swept-source optical coherence tomography (OCT)
Macular hole retinal detachment (MHRD) threatens a certain number of highly myopic patients for irreversible visual dysfunction, and mostly requires immediate surgical intervention. The aim of they study is to evaluate efficacy of vitrectomy with inverted internal limiting membrane (ILM) flap technique for MHRD in highly myopic eyes, and to demonstrate postoperative clinical course of MHRD after inverted ILM flap technique using swept-source optical coherence tomography.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Inverted ILM flap group | Active comparator | Procedure: Vitrectomy | Eyes underwent vitrectomy with inverted internal limiting membrane technique |
| ILM peeling group | Active comparator | Procedure: Vitrectomy | Eyes underwent vitrectomy with internal limiting membrane peeling |
Sex: All, ages: 20 Years to 90 Years
Inclusion Criteria: * The inclusion criteria were patients who underwent vitrectomy and internal limiting membrane removal or inverted for macular hole retinal detachment and had followed for more than 6 months. Exclusion Criteria: * The patients with follow-up less than 6 months.